Humana has yet again hit a 52-week record, reaching $504.99 on Monday.
The health insurer reached new 52-week highs on August 15 and August 19.
Through Monday afternoon trading, the stock is up ~8% year to date, and ~21% over the last year.
A look at its quarterly results helps explain Humana's ( NYSE: HUM ) success. Since fiscal 2017 Q3, it has beat analyst estimates for EPS , and has beaten revenue estimates all but three times from that period through fiscal 2022 Q2, which was just reported in July.
Humana ( HUM ) also has a history of raising its guidance during the year, as it did in July.
For FY2022 Q2 , the insurer said it benefitted from lower utilization than expected and no headwinds from COVID-19 in its Medicare Advantage segment. It expects to add 150K to 200K members in this division alone in FY 2022.
Humana ( HUM ) is also a significant player in Medicaid, which reached an all-time enrollment high during the COV ID-19 pandemic .
The Kaiser Family Foundation has noted that two-thirds of Medicaid beneficiaries are enrolled through managed care organizations and predicts that will enrollment will grow by 25% from 2019 through the end of FY 2022 -- an increase of 22.2M enrollees.
Earlier in August, Humana said it would bolster its Medicaid presence in Wisconsin through its acquisition of managed care organization Inclusa .
For further details see:
Humana keeps hitting new 52-week highs. What's behind its success?